NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors

Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This goal of this study is to test an information and support intervention for patients with malignant (or high-grade) brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18

• Massachusetts General Hospital Cancer Center patient

• Within 6 weeks of diagnosis with a primary malignant brain tumor

• Able to speak and read in English

Locations
United States
Massachusetts
Massachusetts General Hospital Cancer Center
RECRUITING
Boston
Contact Information
Primary
Deborah A Forst, MD
dforst@partners.org
617-724-4000
Time Frame
Start Date: 2023-10-16
Estimated Completion Date: 2026-04-10
Participants
Target number of participants: 50
Treatments
Experimental: NeuroPathways Open Pilot
Enrolled patients will receive an intervention guide with information about navigating life with a brain tumor diagnosis, and will participate in four weekly or biweekly, individual sessions with a clinician (e.g. nurse or behavioral health specialist).~Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks, as well as an exit interview after the intervention.
Experimental: NeuroPathways Pilot RCT
Enrolled patients will receive an intervention guide with information about navigating life with a brain tumor diagnosis, and will participate in four weekly or biweekly, individual sessions with a clinician (e.g. nurse or behavioral health specialist).~Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks.
Active_comparator: Usual supportive care
Participants will receive usual supportive care, which includes referral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician.~Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks.
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov